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Leishmaniasis is a parasitic disease caused by Leishmania species and is classified into three forms; cutaneous, 
mucocutaneous, and visceral. The eyelid is a rare site involved by leishmaniasis and only makes up 2.5% of cases 
with cutaneous leishmaniasis (CL). Although CL can affect both upper and lower lids on either their outer or inner 
aspects, the lateral canthus is most often affected. The most common aspect of lid leishmaniasis is chalazion-like 
lesions but ulcerous, phagedenic, cancer-like forms, and unilateral chronic granulomatous blepharitis may be 
observed. When the lid is involved, the disease is usually self-limiting; healing usually takes up to one year, hence 
early diagnosis and treatment are important. The diagnosis is based on a high index of suspicion regarding the en-
demicity of the disease in the region. Response to treatment in lid CL cases is quite satisfactory. In this article, we 
report nine cases of lid leishmaniasis with satisfactory responses to intralesional meglumine antimoniate.
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Leishmaniasis is a parasitic disease caused by Leishmania, 
transmitted by the bite of some sandfly species and affects 
various age groups [1]. Depending on the infecting Leishmania 
species and host immunocompetence, there are cutaneous, 
mucocutaneous, and visceral forms of the disease [1]. It is es-
timated that 350 million people are at risk of leishmaniasis 
[2, 3]. The disease, in its various forms, affects at least 12 
million people worldwide [3-5], with 1.5 to 2 million new cas-
es per year [2, 3].
Cutaneous leishmaniasis (CL) is endemic in Iran [4]. It 
is usually caused by L. major and L. tropica [4], and typ-
ically presents with a skin ulcer over exposed regions of 
the body after a sandfly bite. It generally heals sponta-
neously within 3-6 months [1].
In addition to the classical picture, several unusual and 
atypical clinical features of the disease have been reported 
in the literature [1,  6], These features may appear at unusual 
sites or may present with atypical morphologies [1]. The 
eyelid is one of the rare sites for the sandfly to bite [6] 
and is the cause for 2.5% of CL cases [3,  7].
Abboud et al. [7] describes some cases of lid CL reported 
by authors from different parts of the world. Herein, we 
described nine cases of lid CL. 
Case Report
Nine cases of lid cutaneous leishmaniasis were referred 
to us between 2002 and 2008 (Fig. 1). All Leishmaniasis 
cases were confirmed by demonstration of typical amasti-
gotes in stained smear with Wright-Eosin-Methylene blue 
prepared from the margin of the lesions (Fig. 2). Charac- 
teristics of our cases were summarized in Table 1. 
In most of our patients, chalazion-like lesions of leish-
maniasis were present. In some cases, lesions were treat-
ed as eczema without any improvement. In one case, the 
diagnosis of chronic blepharitis had been suggested. No 
complication such as involvement of conjunctiva, cornea, 
or sclera was seen. 
Discussion
Symptomatic CL is diverse in its presentation and out-R Yaghoobi, et al. Cutaneous Leishmaniasis of the Lid
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Fig. 1. Cutaneous lid leishmaniasis. (A) A 13-yr-old boy, as ulcerative 
lesion. (B) A 39-yr-old woman manifested as an erythematous 
plaque. (C) A 15-yr-old girl, chalazion-like. (D) A 12-yr-old boy 
manifested as chalazion. (E) A 7-yr-old girl manifested as chalazion. 
(F) A 30-yr-old man manifested as chronic granulomatous 
blepharitis. (G) A 7-yr-old girl, chalazion-like. (H) A 6-mon-old ba-
by, eczema-like. (I) A 6-yr-old boy manifested as classic leish- 
maniasis.
Fig. 2. Typical amastigotes in a stained smear with Wright-Eosin- 
Methylene blue prepared from the margin of the lesions.
come [1]. This clinical diversity is basically governed by the 
parasite, host factors, and immune-inflammatory responses 
[1]. The incubation period of CL varies between several 
weeks to about a year [5].  
The eyelid is rarely involved in the cutaneous form of 
leishmaniasis, possibly due to movement of the lids prevent-
ing the fly vector from biting the skin in this region [2-5,  7]. 
Lid lesions may be caused by the bite, inoculation of the 
lid by the patient's fingers, lymphatic dissemination, the 
Koebner phenomenon (emergence of a new lesion after a 
mechanical trauma), or contiguous spread from a neigh-
boring site [4]. Lid CL may also occur in mucocutaneous 
leishmaniasis, due to L. braziliensis, when infected mate-
rial reaches the lid from nasal mucosal lesions via the na-
solacrimal duct [2,  5].
The typical CL lesion is a solitary ulcerating granuloma 
which starts as a small itching papule and then becomes 
scaled, crusted, and finally ulcerated [5]. When the skin 
of the lids is affected, both upper and lower lids may be 
involved on either their outer or inner aspects [5], most 
often on the lateral canthus [4,  8]. The most common as-
pect of lid leishmaniasis is a chalazion-like lump but ul-
cerous, phagedenic, cancer-like forms [8], and unilateral 
chronic granulomatous blepharitis may be observed [9].
Approximately 2-5% of facial lesions are localized to 
the eyelids [4,  5,  8]. In a study on 718 patients with CL, 
unusual variants were seen in 5.7% of the patients. Lid 
leishmaniasis, as an unusual presentation of CL, was seen 
in 4.9% of unusual cases in the study [1]. Most atypical 
presentations, like paronychial, whitlow, lid, palmoplantar, 
and chancriform are probably related to the normal host 
response to the sandfly bite at these atypical sites [1]. 
The pathologic pattern is comparative to what can be 
observed on the rest of the skin, but eyelid fragility re-
sults in a special risk for local spread [4,  8]. 
Most atypical morphologies are correctly diagnosed, Korean J Ophthalmol Vol.24, No.1, 2010
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Table 1. Summarized characteristics of patients with lid cutaneous leishmaniasis
Case No.  Age (yr) Sex Duration of 
lesions (mon)
Clinical feature of lesions Sites of involvement on the lid
1 13  M 2  Ulcerative The left upper lid
2 39 F 6  Erythematous  plaque
(eczema-like)
The right upper lid
3 15  F 2  Chalazion–like Two lesions on upper and one 
lesion on lower lid of the right eye
4 12  M 3  Chalazion–like The left upper lid
5 7  F 3  Chalazion–like Margin of the right upper lid
6 30  M 2  Chronic blepharitis The right upper lid
7 7  F 1.5 Chalazion-like The right lower lid
8 6  M 2  Classic Leishmaniasis lesion The left upper lid in lateral part
9 6 mon M 1  Erythematous plaque (eczema-like) The right upper and lower lid
keeping a high index of suspicion regarding the ende-
micity of the disease in the region; but in a few cases, there 
is substantial delay. It is after therapeutic unresponsiveness 
and/or further investigations that an ultimate diagnosis of 
atypical CL can be made [1]. Scraping from lesions, es-
pecially early in the infection, show leishman-Donovan bod-
ies which are found mainly within histiocytes, but also 
can be found extracellularly. The presence of these bodies 
from a typical skin lesion was first described by 
Cunningham in 1885 [5].
Clinical diagnosis of ocular leishmaniasis is very difficult 
[4,  10], especially when appearing in non-endemic areas [2]. 
Conjunctiva [4,  7], cornea [7], and sclera are rarely [2] af-
fected, while lachrymal ducts are sometimes [8] affected [4]. 
The disease, particularly its early papulonodular lesion [2], 
may simulate other more common lesions such as chala-
zion, tumors (including basal cell carcinoma, especially 
its ulcerative form) [2-4,  10], dactiocystitis [2,  4], tuber-
culosis (lupus vulgaris), syphilis [5,  10], sarcoidosis [10], 
keratoacanthoma (noular, tumor-like lesions, when ulcerated, 
in older individuals), histoplasmosis, and rhinoscleroma [5]. 
Eczema was also added to the differential diagnosis list 
of lid leishmaniasis.
False diagnoses can be best avoided by taking a detailed 
and accurate history and identifying the pathogens as early 
as possible in smear cultures or by electron microscopy [11].
When the outer aspect of the lid is involved, the dis-
ease is usually self- limiting and healing takes place by 
scarring for up to one year. A much more serious chain 
of events is to be expected when the inner aspect is in-
volved [5]. The contiguous spread from the skin of the 
lid will extend to involve the conjunctiva, sclera, and 
even cornea, with development of interstitial keratitis [2-4]. 
Secondary infection with destruction of underlying soft 
and bony tissue is common [5]. Long-term complications of 
ocular leishmaniasis include lid deformity with all its con-
sequences [3,  4]. Stenosis of the lacrimal duct leads to a 
chronic discharging fistula and secondary conjunctivitis and 
uveitis [5]. Therefore, ocular leishmanisis is considered a po-
tentially blinding disorder; early diagnosis and rigorous treat-
ment may prevent blinding complications [2-4]. Residual 
scarring and deformity may require surgical correction [2]. 
The lid lesions in all our cases improved completely 
without any residual significant complication, because of 
early diagnosis and appropriate therapeutic approach. 
Response to treatment in atypical cases is quite satisfactory [1]. 
Treatment with pentavalent antimonial or sodium stibo-
gluconate (pentostam) is typically curative and more effective. 
The dosage recommended by the World Health Organiz- 
ation is 20 mg/kg per day for 3 weeks [2]. We underwent 
intralesional injection of meglumine antimoniate (glucantime) 
in all our patients. It appeared that this therapeutic regimen 
resulted in a good and relatively rapid response. Because 
of the loose tissue in the eyelid, injection is done easily, 
with the least feeling of pain and in large amount. We 
believe this is the cause of the satisfactory response.
Treatment failure may be due to both delay in di-
agnosis and incomplete therapy, as well as other factors such 
as resistant Leishmania species or deficient host immune 
responses [3].
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